{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:32:51Z","timestamp":1740166371024,"version":"3.37.3"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Inserm GIS-IReSP","award":["AO 8113LS TGIR"],"award-info":[{"award-number":["AO 8113LS TGIR"]}]},{"name":"French Ministry of Health","award":["AOM 09114"],"award-info":[{"award-number":["AOM 09114"]}]},{"DOI":"10.13039\/501100001677","name":"Inserm","doi-asserted-by":"publisher","award":["AO 8022LS"],"award-info":[{"award-number":["AO 8022LS"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006005","name":"Agence de la Biom\u00e9decine","doi-asserted-by":"publisher","award":["R0 8156LL"],"award-info":[{"award-number":["R0 8156LL"]}],"id":[{"id":"10.13039\/501100006005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AURA"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","award":["2009-152-447G"],"award-info":[{"award-number":["2009-152-447G"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this study was to evaluate their respective associations with renal and vital outcomes in CKD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included CKD patients from the NephroTest cohort with concomitant measurements of plasma copeptin and iFGF23 concentrations and isotopic glomerular filtration rate measurement (mGFR). The primary endpoint was a composite outcome including kidney failure (KF) (dialysis initiation, pre-emptive transplantation or a 57% decrease of mGFR, corresponding to doubling of serum creatinine) or death before KF. Hazard ratios (HRs) of the primary endpoint associated with log-transformed copeptin and iFGF23 concentrations were estimated by Cox models. The slope of mGFR over time was analysed using a linear mixed model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 329 CKD patients (243 men, mean age 60.3\u00a0\u00b1\u00a014.6\u00a0years) were included. Among them, 301 with an mGFR &amp;gt;15\u00a0ml\/min\/1.73\u00a0m2 were included in survival and mGFR slope analyses. During a median follow-up of 4.61\u00a0years (quartile 1\u2013quartile 3: 3.72\u20136.07), 61 KFs and 32 deaths occurred. Baseline iFGF23 concentrations were associated with the composite outcome after multiple adjustments {HR 2.72 [95% confidence interval (CI) 1.85\u20133.99]}, whereas copeptin concentrations were not [HR 1.01 (95% CI 0.74\u20131.39)]. Neither copeptin nor iFGF23 were associated with mGFR slope over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our study shows for the first time in population of CKD patients an independent association between iFGF23 and unfavourable renal and vital outcomes and shows no such association regarding copeptin, encouraging the integration of iFGF23 measurement into the follow-up of CKD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfad149","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T21:34:31Z","timestamp":1690320871000},"page":"2472-2481","source":"Crossref","is-referenced-by-count":0,"title":["Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-3733","authenticated-orcid":false,"given":"Arthur","family":"Michon-Colin","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Explorations Fonctionnelles R\u00e9nales \u2013 Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[{"name":"INSERM UMRS 1018, Equipe d'Epid\u00e9miologie Clinique, CESP, Universit\u00e9 Paris-Saclay , Villejuif , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3321-0819","authenticated-orcid":false,"given":"Lise","family":"Bankir","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, INSERM, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"CNRS, ERL 8228, Laboratory of Kidney Physiology and Tubulopathies , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Gauci","sequence":"additional","affiliation":[{"name":"Explorations Fonctionnelles R\u00e9nales \u2013 Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"},{"name":"INSERM UMRS 1018, Equipe d'Epid\u00e9miologie Clinique, CESP, Universit\u00e9 Paris-Saclay , Villejuif , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Brunel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Explorations Fonctionnelles R\u00e9nales \u2013 Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Baron","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Explorations Fonctionnelles R\u00e9nales \u2013 Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"},{"name":"Centre de Recherche des Cordeliers, INSERM, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Prot-Bertoye","sequence":"additional","affiliation":[{"name":"Explorations Fonctionnelles R\u00e9nales \u2013 Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"},{"name":"Centre de Recherche des Cordeliers, INSERM, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"CNRS, ERL 8228, Laboratory of Kidney Physiology and Tubulopathies , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[{"name":"INSERM UMRS 1018, Equipe d'Epid\u00e9miologie Clinique, CESP, Universit\u00e9 Paris-Saclay , Villejuif , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"N\u00e9phrologie et H\u00e9modialyse, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Haymann","sequence":"additional","affiliation":[{"name":"Explorations Fonctionnelles Multidisciplinaires, Sorbonne Universit\u00e9 Paris , France"},{"name":"Explorations Fonctionnelles Multidisciplinaires, H\u00f4pital Tenon, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Boffa","sequence":"additional","affiliation":[{"name":"Explorations Fonctionnelles Multidisciplinaires, Sorbonne Universit\u00e9 Paris , France"},{"name":"N\u00e9phrologie et Dialyse, H\u00f4pital Tenon, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vrtovsnik","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"N\u00e9phrologie, H\u00f4pital Bichat, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Flamant","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Explorations Fonctionnelles Multidisciplinaires, H\u00f4pital Bichat, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Explorations Fonctionnelles R\u00e9nales \u2013 Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"},{"name":"Centre de Recherche des Cordeliers, INSERM, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Prie","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"INSERM U1151, Institut Necker Enfants Malades , Paris , France"},{"name":"D\u00e9partement de Physiologie, H\u00f4pital Necker, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Courbebaisse","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 , Paris , France"},{"name":"Explorations Fonctionnelles R\u00e9nales \u2013 Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique \u2013 H\u00f4pitaux de Paris , Paris , France"},{"name":"INSERM U1151, Institut Necker Enfants Malades , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte , Paris , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the NephroTest Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Philippe","family":"Haymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vrtovsnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vrtovsnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Daugas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Vidal-Petiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Tabibzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Roueff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Courbebaisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Bertocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Prot-Bretoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Fessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Letavernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Haymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Urena-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"2023120101581925500_bib1","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2014-2295","article-title":"Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease","volume":"99","author":"Roussel","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2023120101581925500_bib2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"2023120101581925500_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2023120101581925500_bib4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2023120101581925500_bib5","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2023120101581925500_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MNH.0b013e328351a391","article-title":"Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease","volume":"21","author":"Isakova","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2023120101581925500_bib7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1681\/ASN.2014010104","article-title":"Proteinuria increases plasma phosphate by altering its tubular handling","volume":"26","author":"de Seigneux","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2023120101581925500_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12645","article-title":"Vasopressin: physiology, assessment and osmosensation","volume":"282","author":"Bankir","year":"2017","journal-title":"J Intern Med"},{"key":"2023120101581925500_bib9","first-page":"598","article-title":"Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malm\u00f6 Diet and Cancer Study cardiovascular cohort","volume":"37","author":"Enh\u00f6rning","year":"2013","journal-title":"Int J Obes 2005"},{"key":"2023120101581925500_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort","volume":"77","author":"Meijer","year":"2010","journal-title":"Kidney Int"},{"key":"2023120101581925500_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.ajkd.2012.08.038","article-title":"Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort","volume":"61","author":"Boertien","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2023120101581925500_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MNH.0000000000000335","article-title":"Vasopressin and diabetic nephropathy","volume":"26","author":"Roussel","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"Suppl 1","key":"2023120101581925500_bib13","first-page":"i146","article-title":"Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients","volume":"32","author":"Zittema","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2023120101581925500_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/TP.0b013e3181b11ae4","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients","volume":"88","author":"Meijer","year":"2009","journal-title":"Transplantation"},{"key":"2023120101581925500_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrneph.2013.22","article-title":"Vasopressin: a novel target for the prevention and retardation of kidney disease?","volume":"9","author":"Bankir","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2023120101581925500_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000445959","article-title":"Hydration and chronic kidney disease progression: a critical review of the evidence","volume":"43","author":"Clark","year":"2016","journal-title":"Am J Nephrol"},{"key":"2023120101581925500_bib17","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01880213","article-title":"Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation","volume":"8","author":"Baia","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023120101581925500_bib18","doi-asserted-by":"crossref","first-page":"F745","DOI":"10.1152\/ajprenal.00037.2011","article-title":"Downregulation of Klotho expression by dehydration","volume":"301","author":"Tang","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023120101581925500_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.kint.2018.02.018","article-title":"Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23","volume":"94","author":"Matsui","year":"2018","journal-title":"Kidney Int"},{"key":"2023120101581925500_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"2023120101581925500_bib21","doi-asserted-by":"crossref","first-page":"e0156433","DOI":"10.1371\/journal.pone.0156433","article-title":"Low serum creatine kinase level predicts mortality in patients with a chronic kidney disease","volume":"11","author":"Flahault","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"2023120101581925500_bib22","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"2023120101581925500_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.1985.10","article-title":"A method for estimating nitrogen intake of patients with chronic renal failure","volume":"27","author":"Maroni","year":"1985","journal-title":"Kidney Int"},{"key":"2023120101581925500_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000475769","article-title":"Validation of surrogates of urine osmolality in population studies","volume":"46","author":"Youhanna","year":"2017","journal-title":"Am J Nephrol"},{"key":"2023120101581925500_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","article-title":"Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function","volume":"16","author":"Froissart","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2023120101581925500_bib26","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1111\/ajt.13908","article-title":"Estimated or measured GFR in living kidney donors work-up?","volume":"16","author":"Gaillard","year":"2016","journal-title":"Am J Transplant"},{"key":"2023120101581925500_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2023120101581925500_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2014.08.018","article-title":"GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials","volume":"64","author":"Lambers Heerspink","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2023120101581925500_bib29","doi-asserted-by":"crossref","first-page":"a031260","DOI":"10.1101\/cshperspect.a031260","article-title":"Biology of fibroblast growth factor 23: from physiology to pathology","volume":"8","author":"Courbebaisse","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2023120101581925500_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40885-017-0068-y","article-title":"Pathophysiology of copeptin in kidney disease and hypertension","volume":"23","author":"Afsar","year":"2017","journal-title":"Clin Hypertens"},{"key":"2023120101581925500_bib31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/gfu320","article-title":"Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches","volume":"30","author":"Leffondre","year":"2015","journal-title":"Nephrol Dial Transplant"},{"author":"R Core Team","key":"2023120101581925500_bib32","article-title":"R: a language and environment for statistical computing"},{"key":"2023120101581925500_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfz266","article-title":"Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study","volume":"36","author":"De Jong","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2023120101581925500_bib34","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2023120101581925500_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000479257","article-title":"Inflammation: a key contributor to the genesis and progression of chronic kidney disease","volume":"191","author":"Qian","year":"2017","journal-title":"Contrib Nephrol"},{"key":"2023120101581925500_bib36","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"key":"2023120101581925500_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"2023120101581925500_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40348-021-00123-x","article-title":"How FGF23 shapes multiple organs in chronic kidney disease","volume":"8","author":"Leifheit-Nestler","year":"2021","journal-title":"Mol Cell Pediatr"},{"key":"2023120101581925500_bib39","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"key":"2023120101581925500_bib40","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"2023120101581925500_bib41","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","article-title":"FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis","volume":"289","author":"Coe","year":"2014","journal-title":"J Biol Chem"},{"key":"2023120101581925500_bib42","first-page":"w14509","article-title":"On the relationship between proteinuria and plasma phosphate","volume":"147","author":"de Seigneux","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"2023120101581925500_bib43","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","article-title":"Prevention and treatment of hyperphosphatemia in chronic kidney disease","volume":"93","author":"Vervloet","year":"2018","journal-title":"Kidney Int"},{"key":"2023120101581925500_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0b013e3283621510","article-title":"Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease","volume":"22","author":"Devuyst","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2023120101581925500_bib45","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1373\/clinchem.2016.266254","article-title":"Copeptin associates with cause-specific mortality in patients with impaired renal function: results from the LURIC and the 4D Study","volume":"63","author":"Krane","year":"2017","journal-title":"Clin Chem"},{"key":"2023120101581925500_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfad149\/51015636\/sfad149.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/12\/2472\/53960179\/sfad149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/12\/2472\/53960179\/sfad149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T01:59:09Z","timestamp":1701395949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/16\/12\/2472\/7231797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,7,26]]},"published-print":{"date-parts":[[2023,11,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfad149","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"type":"print","value":"2048-8505"},{"type":"electronic","value":"2048-8513"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,7,26]]}}}